BoneView
GLEAMER- POSITIVE when the confidence for the presence of a lesion is above 90% (plain bounding box around the region of interest)
- DOUBT when the confidence for the presence of a lesion is between 50% and 90% (dotted bounding box around the region of interest)
- NEGATIVE otherwise
BoneView provides a summary table for quality check and overview of AI outputs at a glance, and can perform worklist prioritization according to the different pre-diagnoses.
*In the United States, BoneView has been 510k FDA-cleared for pediatric use and adults (>2 years old for limbs).
Information source:
Vendor
Last updated: March 3, 2025 |
General Information
General | |
---|---|
Product name | BoneView |
Company | GLEAMER |
Subspeciality | MSK |
Modality | X-ray |
Disease targeted | Bone fractures, effusions, dislocations and bone lesions |
Key-features | Detection of fractures, effusions, dislocations and bone lesions, worklist prioritization |
Suggested use | Before: Adapting worklist order, flagging acute findings During: Perception aid (prompting all abnormalities/results/heatmaps) After: Diagnosis verification |
Technical Specifications
Data characteristics | |
---|---|
Population | Adult and pediatric patients with suspicion of fracture |
Input | Bone trauma X-ray |
Input format | DICOM |
Output | Image annotation, pre-diagnosis |
Output format | DICOM, GSPS, DICOM SR |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition |
Processing time | 1 - 10 minutes |
Regulatory
Certification | |
---|---|
CE |
Certified,
Class IIa
, MDR
|
FDA | 510(k) cleared , Class II |
Intended Use Statements | |
Intended use (according to CE) | Provide preliminary data for helping physicians’ diagnosis of extremity X-rays |
Market
Market presence | |
---|---|
On market since | 03-2020 |
Distribution channels | AGFA, Aidoc, Blackford, Carpl.ai, deepcOS, Ferrum, Fujifilm, Incepto, Microsoft (Nuance Communications), Sectra Amplifier Store, Siemens Healthineers, Eureka Clinical AI |
Countries present (clinical, non-research use) | >40 |
Paying clinical customers (institutes) | >650 |
Research/test users (institutes) | |
Pricing | |
Pricing model | Subscription |
Based on | Number of users, Number of installations, Number of analyses |
Evidence
Evidence | |
---|---|
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |